Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04990037
Title A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (CAPAFOUR)
Acronym CAPAFOUR
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cantargia AB
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
EDOG - Institut Bergonie - PPDS Bordeaux 33000 France Details
EDOG Institut de Cancerologie de l'Ouest - PPDS Nantes 44100 France Details
EDOG - Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer - PPDS Rennes France Details
Institut de Cancerologie de l'Ouest Saint-Herblain 44805 France Details
Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON Barcelona 08035 Spain Details
ICO l'Hospitalet - Hospital Duran i Reynals Barcelona 08908 Spain Details
Hospital General Universitario Gregorio Maranon Madrid 28007 Spain Details
START MADRID_Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field